These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36376143)

  • 21. Evaluation of Eligibility Criteria Used to Identify Patients for Medication Therapy Management Services: A Retrospective Cohort Study in a Medicare Advantage Part D Population.
    Lee JS; Yang J; Stockl KM; Lew H; Solow BK
    J Manag Care Spec Pharm; 2016 Jan; 22(1):22-30. PubMed ID: 27015048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Understanding the Socioeconomic and Geographical Characteristics of Beneficiaries Receiving a Comprehensive Medication Review.
    Chou J; Pellegrin K; Cooke CE; Zarowitz B; Hanlon A; Lozano A; Brandt NJ
    J Manag Care Spec Pharm; 2020 Oct; 26(10):1276-1281. PubMed ID: 32996388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Historical trend of disparity implications of Medicare MTM eligibility criteria.
    Wang J; Qiao Y
    Res Social Adm Pharm; 2013; 9(6):758-69. PubMed ID: 23062785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Medicare comprehensive medication review on racial/ethnic disparities in nonadherence to statin medications among patients with Alzheimer's Disease: an observational analysis.
    Browning JA; Tsang CCS; Dong X; Wan JY; Chisholm-Burns MA; Finch CK; Tsao JW; Liu C; Wang J
    BMC Health Serv Res; 2022 Feb; 22(1):159. PubMed ID: 35130899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-Effectiveness Analysis of a Pharmacist-Led Medication Therapy Management Program: Hypertension Management.
    Schultz BG; Tilton J; Jun J; Scott-Horton T; Quach D; Touchette DR
    Value Health; 2021 Apr; 24(4):522-529. PubMed ID: 33840430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Medication Therapy Management Services and Their Effects on Health Care Utilization and Medication Adherence.
    Ferries E; Dye JT; Hall B; Ndehi L; Schwab P; Vaccaro J
    J Manag Care Spec Pharm; 2019 Jun; 25(6):688-695. PubMed ID: 31134865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medication Therapy Management: 10 Years of Experience in a Large Integrated Health Care System.
    de Oliveira DR; Brummel AR; Miller DB
    J Manag Care Spec Pharm; 2020 Sep; 26(9):1057-1066. PubMed ID: 32857651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of telephone medication therapy management on medication and health-related problems, medication adherence, and Medicare Part D drug costs: a 6-month follow up.
    Moczygemba LR; Barner JC; Lawson KA; Brown CM; Gabrillo ER; Godley P; Johnsrud M
    Am J Geriatr Pharmacother; 2011 Oct; 9(5):328-38. PubMed ID: 21865093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Medicare Part D medication therapy management on racial/ethnic disparities in adherence to antidementia medications among patients with Alzheimer's disease and related dementias: An observational study.
    Dong X; Tsang CCS; Wan JY; Chisholm-Burns MA; Finch CK; Tsao JW; Browning JA; Garuccio J; Zeng R; Wang J
    Explor Res Clin Soc Pharm; 2024 Mar; 13():100420. PubMed ID: 38420610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years.
    Barnett MJ; Frank J; Wehring H; Newland B; VonMuenster S; Kumbera P; Halterman T; Perry PJ
    J Manag Care Pharm; 2009; 15(1):18-31. PubMed ID: 19125547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of a Medicare MTM program: evaluating clinical and economic outcomes.
    Hui RL; Yamada BD; Spence MM; Jeong EW; Chan J
    Am J Manag Care; 2014 Feb; 20(2):e43-51. PubMed ID: 24738554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Historical trend of racial and ethnic disparities in meeting Medicare medication therapy management eligibility in non-Medicare population.
    Wang J; Surbhi S; Zhang Z; Spivey CA; Chisholm-Burns M
    Res Social Adm Pharm; 2014; 10(6):904-917. PubMed ID: 25458405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Should eligibility for medication therapy management be based on drug adherence?
    Stuart B; Loh E; Miller L; Roberto P
    J Manag Care Pharm; 2014 Jan; 20(1):66-75. PubMed ID: 24511767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conjoint analysis of patient preferences on Medicare medication therapy management.
    Hong SH; Liu J; Wang J; Brown L; White-Means S
    J Am Pharm Assoc (2003); 2011; 51(3):378-87. PubMed ID: 21555290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Evaluation of the Cost-effectiveness of Comprehensive MTM Integrated with Point-of-Care Phenotypic and Genetic Testing for U.S. Elderly Patients After Percutaneous Coronary Intervention.
    Okere AN; Ezendu K; Berthe A; Diaby V
    J Manag Care Spec Pharm; 2018 Feb; 24(2):142-152. PubMed ID: 29384027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of medication therapy management services for patients with cardiovascular disease in a self-insured employer health plan.
    Wittayanukorn S; Westrick SC; Hansen RA; Billor N; Braxton-Lloyd K; Fox BI; Garza KB
    J Manag Care Pharm; 2013 Jun; 19(5):385-95. PubMed ID: 23697476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring Racial and Ethnic Disparities in Medication Adherence Among Medicare Comprehensive Medication Review Recipients.
    Dong X; Tsang CCS; Wan JY; Shih YT; Chisholm-Burns MA; Dagogo-Jack S; Cushman WC; Hines LE; Wang J
    Explor Res Clin Soc Pharm; 2021 Sep; 3():. PubMed ID: 35434697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of a Clinical Pharmacist Medication Therapy Management Program in Discontinuation of Drugs to Avoid in the Elderly.
    Caffiero N; Delate T; Ehizuelen MD; Vogel K
    J Manag Care Spec Pharm; 2017 May; 23(5):525-531. PubMed ID: 28448783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medication therapy management: 10 years of experience in a large integrated health care system.
    Ramalho de Oliveira D; Brummel AR; Miller DB
    J Manag Care Pharm; 2010 Apr; 16(3):185-95. PubMed ID: 20331323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Racial/ethnic disparities in measure calculations for Part D Star Ratings among Medicare beneficiaries with diabetes, hypertension, and/or hyperlipidemia.
    Steve Tsang CC; Wan JY; Chisholm-Burns MA; Li M; Dagogo-Jack S; Cushman WC; Hines LE; Wang J
    Res Social Adm Pharm; 2021 Aug; 17(8):1469-1477. PubMed ID: 33272859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.